Product
Liposomal Mitoxantrone
Aliases
Part 1, Part 1: Liposomal mitoxantrone hydrochloride and Pegaspargase
2 clinical trials
3 indications
Indication
Extranodal NK/T-cell LymphomaIndication
Nasal TypeIndication
Non-Hodgkin LymphomaClinical trial
A Multicentre, Open-label, Single-arm, Phase I/II Clinical Study to Evaluate the Safety, Efficacy and Pharmacokinetic Characteristics of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCLStatus: Terminated, Estimated PCD: 2022-01-30
Clinical trial
Liposomal Mitoxantrone Hydrochloride, Gemcitabine, Vinorelbine With or Without Rituximab (GVM±R) in Patients With Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaStatus: Active (not recruiting), Estimated PCD: 2023-12-18